JP2008525033A - B群連鎖球菌 - Google Patents

B群連鎖球菌 Download PDF

Info

Publication number
JP2008525033A
JP2008525033A JP2007548453A JP2007548453A JP2008525033A JP 2008525033 A JP2008525033 A JP 2008525033A JP 2007548453 A JP2007548453 A JP 2007548453A JP 2007548453 A JP2007548453 A JP 2007548453A JP 2008525033 A JP2008525033 A JP 2008525033A
Authority
JP
Japan
Prior art keywords
protein
family
proteins
conserved virtual
virtual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007548453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525033A5 (cg-RX-API-DMAC7.html
Inventor
エルベ テッテリン,
ヴェガ マシグナニ,
Original Assignee
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド filed Critical ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド
Publication of JP2008525033A publication Critical patent/JP2008525033A/ja
Publication of JP2008525033A5 publication Critical patent/JP2008525033A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007548453A 2004-12-22 2005-12-21 B群連鎖球菌 Pending JP2008525033A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63894304P 2004-12-22 2004-12-22
US64043804P 2004-12-30 2004-12-30
PCT/US2005/046491 WO2006069200A2 (en) 2004-12-22 2005-12-21 Group b streptococcus

Publications (2)

Publication Number Publication Date
JP2008525033A true JP2008525033A (ja) 2008-07-17
JP2008525033A5 JP2008525033A5 (cg-RX-API-DMAC7.html) 2009-07-23

Family

ID=36602309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548453A Pending JP2008525033A (ja) 2004-12-22 2005-12-21 B群連鎖球菌

Country Status (8)

Country Link
US (1) US20090104218A1 (cg-RX-API-DMAC7.html)
EP (1) EP1828231A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008525033A (cg-RX-API-DMAC7.html)
AU (1) AU2005319174A1 (cg-RX-API-DMAC7.html)
CA (1) CA2591510A1 (cg-RX-API-DMAC7.html)
IL (1) IL183830A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007007033A (cg-RX-API-DMAC7.html)
WO (1) WO2006069200A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015520605A (ja) * 2012-03-30 2015-07-23 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company 過酸生成に有用な酵素
JP5986931B2 (ja) * 2011-02-02 2016-09-06 公益財団法人微生物化学研究会 血液脳関門を透過する薬物輸送体、ペプチド及びその用途

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
KR100790653B1 (ko) 1998-12-22 2007-12-31 마이크로싸이언스 리미티드 유전자와 단백질들, 및 그들의 사용
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド StreptococcusPyogenesについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1807446A2 (en) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
EP1801235A1 (en) * 2005-12-20 2007-06-27 Institut Pasteur Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
JP2009540819A (ja) * 2006-06-19 2009-11-26 ミュタビリス エス アー B群レンサ球菌の病原性に関与する遺伝子の同定
US20100150943A1 (en) * 2006-07-26 2010-06-17 Novartis Ag Immunogenic compositions for gram positive bacteria
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Gas57変異体抗原およびgas57抗体
EP2135877A1 (en) 2008-06-19 2009-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
US8147849B2 (en) 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
AU2010273708B2 (en) 2009-06-29 2015-10-01 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
MY163871A (en) 2011-01-20 2017-10-31 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae
EP2557424A1 (en) * 2011-08-11 2013-02-13 InGen Biosciences Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
WO2013124473A1 (en) * 2012-02-24 2013-08-29 Novartis Ag Pilus proteins and compositions
RU2015106791A (ru) 2012-10-03 2016-11-20 Глэксосмитиклайн Байолоджикалз Са Иммуногенные композиции
EP3021864A1 (en) * 2013-07-16 2016-05-25 Université de Lausanne Bacterial lysins and uses thereof
AR101455A1 (es) * 2014-08-05 2016-12-21 Glaxosmithkline Biologicals Sa Molécula portadora
SG11201806639VA (en) 2016-02-04 2018-09-27 Genovis Ab New streptococcal proteases
WO2018204153A1 (en) * 2017-05-02 2018-11-08 Venomyx, Inc. Composition and methods for treating snake envenomation
WO2018237010A2 (en) * 2017-06-20 2018-12-27 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vaccine compositions and methods of using the same
PL239045B1 (pl) * 2018-01-09 2021-11-02 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
GB2590210B (en) * 2018-06-13 2023-01-25 Gen Probe Inc Compositions and methods for detecting group B Streptococcus nucleic acid
RU2021105821A (ru) 2018-08-06 2021-05-27 Медикайн, Инк. Соединения, связывающие рецептор il-2
WO2021092075A1 (en) 2019-11-05 2021-05-14 Medikine Inc. IL-2RβγC BINDING COMPOUNDS
WO2021108929A1 (en) * 2019-12-06 2021-06-10 Theratechnologies Inc. Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
WO2021158623A1 (en) 2020-02-03 2021-08-12 Medikine, Inc. IL-7Rαγc BINDING COMPOUNDS
AU2021219847A1 (en) * 2020-02-12 2022-10-13 Massachusetts Institute Of Technology Field deployable CRISPR-Cas diagnostics and methods of use thereof
US11453907B2 (en) 2020-03-23 2022-09-27 The Broad Institute, Inc. Crispr effector system based coronavirus diagnostics
WO2022026534A1 (en) * 2020-07-28 2022-02-03 Kansas State University Research Foundation Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
CA3197344A1 (en) * 2020-11-04 2022-05-12 William J. Dower Il-2r.beta.yc binding compounds and uses thereof
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins
WO2025017062A1 (en) * 2023-07-18 2025-01-23 Intervet International B.V. New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
WO2025151408A1 (en) * 2024-01-08 2025-07-17 Denali Therapeutics Inc. Compositions and methods for modulating tau expression

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001309795A (ja) * 1989-09-15 2001-11-06 General Hospital Corp:The B群連鎖球菌に対する複合ワクチンを製造するための防御的タンパク質抗原をコードする遺伝子配列からなる組換え分子
JP2002512026A (ja) * 1998-04-20 2002-04-23 カイロン エセ.ピー.アー. B群連鎖球菌の糖質を免疫学的に模倣する抗イディオタイプ抗体を含むワクチン処方物
JP2002531054A (ja) * 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド B群連鎖球菌由来の核酸およびタンパク質
JP2003527100A (ja) * 1999-09-07 2003-09-16 ミクロバイアル・テクニクス・リミテッド タンパク質
WO2004048404A2 (en) * 2002-11-22 2004-06-10 Chiron Srl Multiple variants of meningococcal protein nmb1870

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1328543B1 (en) * 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
CN1705679B (zh) * 2002-10-15 2011-04-06 英特塞尔股份公司 编码b族链球菌粘着因子的核酸、b族链球菌的粘着因子和它们的用途

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001309795A (ja) * 1989-09-15 2001-11-06 General Hospital Corp:The B群連鎖球菌に対する複合ワクチンを製造するための防御的タンパク質抗原をコードする遺伝子配列からなる組換え分子
JP2002512026A (ja) * 1998-04-20 2002-04-23 カイロン エセ.ピー.アー. B群連鎖球菌の糖質を免疫学的に模倣する抗イディオタイプ抗体を含むワクチン処方物
JP2002531054A (ja) * 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド B群連鎖球菌由来の核酸およびタンパク質
JP2003527100A (ja) * 1999-09-07 2003-09-16 ミクロバイアル・テクニクス・リミテッド タンパク質
WO2004048404A2 (en) * 2002-11-22 2004-06-10 Chiron Srl Multiple variants of meningococcal protein nmb1870

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5986931B2 (ja) * 2011-02-02 2016-09-06 公益財団法人微生物化学研究会 血液脳関門を透過する薬物輸送体、ペプチド及びその用途
JP2015520605A (ja) * 2012-03-30 2015-07-23 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company 過酸生成に有用な酵素

Also Published As

Publication number Publication date
US20090104218A1 (en) 2009-04-23
IL183830A0 (en) 2007-10-31
MX2007007033A (es) 2007-08-03
AU2005319174A1 (en) 2006-06-29
WO2006069200A2 (en) 2006-06-29
CA2591510A1 (en) 2006-06-29
EP1828231A2 (en) 2007-09-05
WO2006069200A3 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
JP2008525033A (ja) B群連鎖球菌
US10428121B2 (en) Nucleic acids and proteins from streptococcus groups A and B
US7749518B2 (en) Polypeptides from non-typeable Haemophilus influenzae
US9034642B2 (en) Genes of an otitis media isolate of nontypeable Haemophilus influenzae
ES2569654T3 (es) Proteínas y ácidos nucleicos de la meningitis / sepsis asociada a la Escherichia coli
US6617156B1 (en) Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US7090973B1 (en) Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
US20120093868A1 (en) Haemophilus influenzae type b
CN101203529A (zh) 来自脑膜炎/脓毒症相关性大肠杆菌的蛋白质和核酸
WO2004018646A2 (en) Conserved and specific streptococcal genomes
AU2012207041A1 (en) Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli
EP1980266A1 (en) New virulence factors of Streptococcus pneumoniae
HK1133019A (en) Genes of an otitis media isolate of nontypeable haemophilus influenzae

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110728

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120112